ABER INSTRUMENTS LTD.

Company Snapshot

Founded: 1988
Entity Type: Private
Region: U.K.
Headquarter: Aberystwyth, U.K.
Key Geographics: Europe, North America
Corporate Address: Science Park, Aberystwyth, SY23 3AH U.K. Tel. +44-0-1970-636-300 www.aberinstruments.com

Company Overview

Aber Instruments Ltd. is a U.K.-based company established in 1998. The company produces a range of advanced systems used in the brewing, biotech, bio-renewables, and biofuel industries. The company partnered with Sartorius AG for the development of single-use technology in the biotech segment. In addition, the company offers research and process development services for various industries. The company provides process development and manufacturing for cell culture, including suspension cells, microcarrier culture and packed beds, cell culture production, and control of constant cell concentrations. It offers process development of cell culture for various microbial applications such as high-density yeast fermentations, pichia fermentations, bacterial fermentation, and mycelial fermentations.

Under the biotech segment, the company offers a range of biotechnology products including three hardware components and numerous software products for system configuration, data logging, data analysis, and frequency scanning. It provides 12 mm, 25 mm, tri-clamp bioreactors under the FUTURA brand. The company has partnerships with companies including Glaxo Smithkline and Novartis.

ABER INSTRUMENTS LTD. In Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029 at a CAGR of...

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Report for Single-use Biopharmaceutical’s technologies. Get market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs....

Single-use Technologies for Biopharmaceuticals: Global Markets

The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate of 11.3% for the period of 2019 to 2024.

Company's Business Segments

  • Cell Measuring Technology : Manufactures a range of on-line probes for measuring or counting the live cell concentration in fermenters, cell culture bioreactors and in brewing applications.

Applications/End User Industries

  • Biotechnology
  • Biomass Monitor
  • Yeast Monitor
  • Biopharma
  • Futura Biomass Monitor
AI Sentiment